1. Nearly three in four CFOs and half of CEOs received base salary increases.
Among executives in the 2023 study, 72% of CFOs and 50% of CEOs received salary increases, slightly lower than 2022’s findings.
2. The median change in base salary held steady for CFOs, while increases were flat for CEOs.
The median change in base salary for CFOs in 2023 was 4%, near the 3.8% increase in 2022. There was a 0% median salary change for CEOs in 2023, compared with a 2.9% increase in 2022.
3. Long-term incentive awards increased at a higher rate than last year.
Awards increased 11% for CFOs and 9% for CEOs in 2023, compared with 7% and 5%, respectively, in 2022.
4. Total cash compensation in healthcare aligned with industries.
Median total cash compensation increases for healthcare were -4% for CEOs and 4% for CFOs, similar to other industries in the study such as financials, utilities and industrials.
5. Amid compensation trends, CFO turnover remains higher than CEO turnover.
The median tenure in 2023 was five years for CFOs and seven years for CEOs.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
